Turner Syndrome Clinical Trial
Official title:
Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome
The purpose of this research study is to learn about brain development in very young girls with Turner syndrome (TS) and the effect that growth hormone (GH) therapy has on early brain development.
Studies in older children and adults have found that IQ in individuals with Turner syndrome
(TS) and the general population are similar. However, many individuals with TS have a
nonverbal learning disability which may cause problems with imagining and working with
objects in space (for example: building blocks, working puzzles, copying designs, driving a
car) as well as problems in planning, paying attention, and getting along with people their
own age. Studies of brain structure have found changes in the size and function of specific
areas of the brain that are involved in these nonverbal processes. However, there are no
data published on brain structure or function in girls with Turner Syndrome in the first few
years of life when brains are learning and growing most rapidly.
In a recent study, very young, short girls with Turner Syndrome (TS)(averaging 2 years in
age) were treated with Growth Hormone (GH) and almost reached an average height after 2
years. The risks of GH for the young girls in that study appeared to be the same as those
for older girls. Therefore, it is now recommended that GH therapy be considered as soon as a
child with TS has growth failure. Growth failure often occurs during infancy; therefore,
more children with TS are now receiving GH therapy as young as 12 months of age. In this
study, the investigators wish to start understanding what effect GH has on learning and
brain growth when given between the ages of 12 and 24 months. In this study, the girls with
TS will have developmental studies, a physical examination, magnetic resonance imaging
(MRI), and blood drawn at one and two years of age. Some of the girls in this study will
receive GH from 12 until 24 months of life, while others will not. Brain growth and
development will be compared between those who have been treated with GH and those who have
not. This is a pilot study in which the investigators will gather data to design a larger
study that can answer these questions.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01734486 -
Growth Response in Girls With Turner Syndrome
|
Phase 4 | |
| Completed |
NCT01678261 -
X-chromosome Inactivation, Epigenetics and the Transcriptome
|
N/A | |
| Completed |
NCT01419249 -
First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study
|
Phase 4 | |
| Completed |
NCT01518036 -
Use of Somatropin in Turner Syndrome
|
Phase 3 | |
| Recruiting |
NCT04948658 -
Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy
|
||
| Completed |
NCT01563926 -
Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency
|
Phase 3 | |
| Completed |
NCT02787486 -
Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
|
||
| Completed |
NCT00877942 -
Sex Differences in Early Brain Development; Brain Development in Turner Syndrome
|
N/A | |
| Completed |
NCT00825617 -
Quantitative Liver Functions in Turner Syndrome With and Without Hormone Replacement Therapy
|
N/A | |
| Recruiting |
NCT04463316 -
GROWing Up With Rare GENEtic Syndromes
|
||
| Enrolling by invitation |
NCT03836300 -
Parent and Infant Inter(X)Action Intervention (PIXI)
|
N/A | |
| Completed |
NCT01245374 -
Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents
|
Phase 4 | |
| Completed |
NCT01322165 -
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
|
N/A | |
| Terminated |
NCT00419107 -
Beta Cell Function in Women With Turner Syndrome
|
N/A | |
| Active, not recruiting |
NCT00625001 -
Long Term Follow-up of Bone Mineral Density in Hormone Treated Turner Syndrome
|
N/A | |
| Completed |
NCT00029159 -
The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome
|
Phase 3 | |
| Completed |
NCT01518062 -
Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner Syndrome
|
Phase 4 | |
| Completed |
NCT00471731 -
Dry Eye in Women With Turner Syndrome and Women With Premature Ovarian Failure
|
N/A | |
| Completed |
NCT00256126 -
Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN®
|
Phase 4 | |
| Completed |
NCT03181230 -
Health, Fitness, and Quality of Life in Adolescent Girls With Turner Syndrome
|